Rheumatoid Arthritis Clinical Trials in New York

Showing 961-980 of 4,168 trials

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

NCT06376162

The primary objective of the study is to determine the recommended phase 2 dose (RP2D) of ziftomenib in combination with chemotherapy (FLA) in children with relapsed or refractory KMT2A-r, NUP98-r, or NPM1-m acute leukemia based on safety and pharmacokinetics (PK).

Relapsed/Refractory KMT2A-r Acute LeukemiaRelapsed/Refractory NUP98-r Acute LeukemiaRelapsed/Refractory NPM1-m Acute Leukemia

PedAL BCU, LLC20 participantsStarted Mar 2025

Los Angeles, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +17 more locations

COMPLETEDPhase 2< 1 mile

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

NCT03782792

To evaluate efficacy, safety, and tolerability of spesolimab (BI 655130) compared to placebo in patients with Generalized Pustular Psoriasis (GPP) presenting with an acute flare of moderate to severe intensity.

Generalized Pustular Psoriasis

Boehringer Ingelheim53 participantsStarted Jan 2019

Birmingham, Alabama, United States • Miami, Florida, United States • Tampa, Florida, United States +34 more locations

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Rheumatoid Arthritis Trials in Other Cities

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Integrated Model for Promoting Parenting and Early School Readiness in Pediatrics

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

Longitudinal Study of Mitochondrial Hepatopathies

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

Intent of Surgery for IPMN

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

RELAXaHEAD for Headache Patients (Phase III)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)

Ultrasound Stimulation for Patients in a Disorder of Consciousness

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Other Conditions in New York